Endocrine Tumors
Specialized treatment for adrenal, pituitary, and neuroendocrine tumors.
Overview
Endocrine tumors arise from hormone-producing tissues and include neuroendocrine tumors (NETs), adrenal cancers, pituitary tumors, and carcinoid tumors. These cancers often require specialized knowledge of both oncology and endocrinology.
Our team uses somatostatin receptor imaging (Gallium 68 DOTATATE PET) and targeted radionuclide therapy (Lutathera) alongside standard systemic treatments.
Symptoms & Warning Signs
- Hormonal symptoms (flushing, diarrhea, wheezing)
- Abdominal pain
- Unexplained weight changes
- Fatigue
- Skin changes
Diagnosis & Evaluation
Specialized Imaging
Ga68 DOTATATE PET/CT
Biopsy
Tissue sampling with Ki-67 grading
Biochemical Markers
Chromogranin A, 5-HIAA, and hormone levels
Treatment Options
Frequently Asked Questions
What is a neuroendocrine tumor?
NETs arise from neuroendocrine cells found throughout the body. They can be slow-growing (low-grade) or aggressive (high-grade) and may produce excess hormones.
What is Lutathera?
Lutathera (Lu-177 DOTATATE) is a targeted radionuclide therapy that delivers radiation directly to NET cells expressing somatostatin receptors.
